1Quaedackers M E,Christina E,Brink V D,et al.4-Hydroxytamoxifen trans-represses NF-κB activity[J].Endocrinology,2001,142:1156-1165.
2Hall J M, Mcdonnell D P.ERβ-modulation of ERα transcription activity[J].Endocrinology,1999,140:5566-5578.
3McInerney E M,Weis K E,Sun J,et al.ERβ transcription activation[J].Endocrinology,1998,139:4513-4522.
4Hall J M,McDonnell D P,Korach K S.Regulation of coactivatorrecruitment[J].Mol Endocrinol,2002,16:469-486.
5Robyr D,Wolffe A P,Wahli W.Nuclear hormone receptorcoregulation[J].Mol Endocrinol,2000,14:329-337.
6Levin E R.Cellular functions of plasma membrane estrogenreceptors[J].Steroids,2002,67:471-475.
7Watters J J,Campbell J S,Cunningham M J,et al.Rapid membrane effect of steroids[J].Endocrinology,1997,138:4030-4033.
8Keshamouni V G ,Mattingly R R,Reddy K B.A role for HER2 andPKC-delta[J].J Biol Chem,2002,277:22558-22565.
9Song R X,Mcpherson R A,Adan L,et al.Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathwayactivation[J].Mol Endocrinol,2002,16:116-127.
10Filardo E J,Quinn J A,Frackelton A R,et al.Estrogen action viaGPCR[J].Mol Endocrinol,2002,16:70-84.
